University of Missouri-Columbia
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, University of Missouri-Columbia sits in the top decile of US sponsors by registered trial count (#120 of 15,742 sponsors by registered trial count).
University of Missouri-Columbia: 291 sponsored US clinical trials, 54 recruiting.
University of Missouri-Columbia sponsors 291 registered US clinical trials on ClinicalTrials.gov, 54 of them currently recruiting, and 170 completed. 29 of these trials are in Phase 3-4 (later-stage) and 38 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obesity, with 8 trials.
Top-decile sponsor footprint
University of Missouri-Columbia ranks in the top decile of sponsors by registered trial count (#120 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
170 of 224 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (75.9%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
291 total, page 6 of 6
Bilateral Versus Unilateral Task Retraining Using the SaeboFlex Orthosis
NCT00893776
Inferior Turbinate Reduction in Pediatric Population Failing Surgery for Sleep Disordered Breathing
NCT00936494
Using Health Information Technology (HIT) to Improve Ambulatory Chronic Disease Care: Smart Device Substudy
NCT00802152
Dexmedetomidine and Hypoxic Pulmonary Vasoconstriction in Thoracic Surgical Procedures and One-Lung Ventilation
NCT00839605
Targeting Sympathetic Overactivity in Heart Failure Patients With Statins
NCT01097785
Incisional Vacuum Assisted Closure (IVAC) Device and Its Effect on Implanted Bone Morphogenic Protein (BMP-2)
NCT00829621
Early Motion Following Carpal Tunnel Release
NCT00845325
Weaning Thermoregulatory Support in Preterm Neonates
NCT00769262
Brief Motivational Intervention to Increase Physical Activity and Fruit/Vegetable Intake
NCT01075139
Sublingual Immunotherapy for Food Allergy
NCT00736281
Serum Procalcitonin Study in the Management of Ventilated Patients
NCT00726167
Medication Adherence in Hypertension Study
NCT00688350
Physical Activity and Dietary Behaviors of Adults 18 to 80 Years of Age
NCT00641849
Early Detection of Diastolic Dysfunction and the Role of Lifestyle Measures in Its Treatment
NCT00998114
Treatment of Unresectable Hepatocellular Cancer With Opioid Growth Factor
NCT00706576
Osteogenic Cell Viability in Bone Graft
NCT00843973
Early Diagnosis of Diastolic Dysfunction and Reliability of DSE in Detecting Stress Diastolic Dysfunction
NCT00998205
Does Treatment With Macrobid Reduce Urinary Tract Infections in Patients Receiving a Sub-Urethral Sling for Incontinence
NCT00734968
Role of Vacuum Assisted Closure (VAC) Device in Postoperative Management of Pelvic and Acetabular Fractures
NCT00635479
Integrating Targeted MedlinePlus Health Prescriptions Into Clinic Practice Workflow
NCT00634608
Antibiotic Prophylaxis in Orthopaedic Traumatology
NCT00610987
Efficacy of Plyometrics to Increase Bone Mass in Men With Osteopenia
NCT00572104
Rhinogenic Headache Improvement After Nasal Operation
NCT00580307
Pilot Study of a Homeopathic Therapy in Combination With Cyclosporin (Restasis) in the Treatment of Dry Eye Disease
NCT01072526
Foot and Ankle Range of Motion (Stretching) Apparatus
NCT00527748
Pilot Study to Identify the Influence of Genetic Profile Aberrations on Patients With Recurrent Hernias
NCT00527670
Clinical Evaluation of Spring-Type Laparoscopic Clip Technology
NCT00527644
Combined Ketamine/Propofol for Emergency Department Procedural Sedation
NCT01126957
Effect of Namenda on Short Term Memory and Attention in Patients With Mild to Moderate Traumatic Brain Injury
NCT00462228
Characterization of Explanted Hernia Meshes From Human Subjects: A Multi-Center, Prospective Study
NCT00484887
The Psychosocial Effect of Thoughts of Personal Mortality on Cardiac Risk Assessment by Medical Students
NCT00500136
Ulcer Prevention Study in Post Gastric Bypass Patients
NCT00557349
Partial Word Knowledge Growth in Children With LLD
NCT00547833
Prospective Study Comparing Different Modalities of Oxygen Delivery During Assessment of Functional Exercise Capacity
NCT00484562
Lateral Versus Anterior Spanning External Fixator for Tibial Plateau Fractures
NCT00610701
Exercise and Physical Fitness for Persons With Knee Osteoarthritis
NCT00265447
High-speed Power Training in Older Adults With Knee Osteoarthritis (OA)
NCT01328340
Feet First: Promoting Physical Activity Among People With Diabetes Mellitus and Insensate Feet
NCT00286598
RAHelp.Org: An Online Self Management Program for Adults With Rheumatoid Arthritis
NCT00283855
Work Interventions to Improve Employment Outcomes for Persons With Rheumatoid Arthritis and Osteoarthritis
NCT00485914
Supplementation With Vitamin D, Calcium or Both on Calcium Absorption and Bone Mineral Content in Children With JRA
NCT00570934
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 26 |
| Phase 2 | 12 |
| Phase 3 | 4 |
| Phase 4 | 25 |
Therapeutic Areas
What is open in the University of Missouri-Columbia pipeline
54 recruiting of 291 indexed (19% open); 170 completed (58%).
Phase mix: 29 late (III/IV) vs 38 early (I/II) (balanced across stages).
Top condition: Obesity (8 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Missouri-Columbia: open-pipeline peers nationwide
Peers matched on 291 registered trials and 19% open enrollment, not the therapeutic-area sidebar.
University of Missouri-Columbia sits below the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 291 trials (± recruiting share)
- Thomas Jefferson University · 292 trials · 18% recruiting
- University of Michigan Rogel Cancer Center · 292 trials · 15% recruiting
- Kaiser Permanente · 294 trials · 7% recruiting
- Eisai · 287 trials · 2% recruiting
Sponsors near 19% open enrollment (± trial volume)
- Arkansas Children's Hospital Research Institute · 19% recruiting · 97 trials
- Montefiore Medical Center · 19% recruiting · 345 trials
- Children's Hospital Medical Center, Cincinnati · 19% recruiting · 571 trials
- Mclean Hospital · 19% recruiting · 140 trials
Related
What to do with this University of Missouri-Columbia page
291 registered trials is a research-attention snapshot, not an endorsement of University of Missouri-Columbia or any single study.
- 54 of University of Missouri-Columbia's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Obesity is the condition University of Missouri-Columbia studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Obesity trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
University of Missouri-Columbia pipeline card: 291 registered trials from official public datasets.Report a data error.